Item 8.01 Other Events.
We previously disclosed in our Current Report on Form 8-K dated November 12,
2020 (as subsequently amended by our Current Report on Form 8-K/A dated on
November 13, 2019) (collectively, the "November 12 8-K") that our private
placement of 9,765,933 shares of our common stock and warrants to purchase
9,765,933 shares of our common stock resulting in aggregate gross proceeds to us
of approximately $18.1 million (the "Private Placement") would close
simultaneously with the consummation of our Agreement and Plan of Merger and
Reorganization with MyMD Pharmaceuticals, Inc. and XYZ Merger Sub, Inc. (also
reported in the November 12 8-K). Notwithstanding the prior disclosure, the
Private Placement is expected to close on or around November 16, 2020.
© Edgar Online, source Glimpses